Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

APCCC 2022 | PSMA-PET scanning and management of cN1 prostate cancer

Darren Poon • 18 May 2022
APCCC 2022
Genitourinary Cancer Prostate Cancer

Darren Poon, MBChB, FRCR, FHKCR, FHKAM, The Chinese University of Hong Kong, Hong Kong discusses the novel prostate specific antigen (PSMA) PET scan technique for prostate cancer. Dr. Poon describes how data gathered in future studies will provide insight into the applications of novel imaging techniques to the management of locally advanced prostate cancer, particularly clinically node-positive (cN1) prostate cancer. This interview took place at the APCCC 2022 conference, held in Lugano, Switzerland.

More from Darren Poon

Local and systemic therapies for cN1 prostate cancer
2:00
Local and systemic therapies for cN1 prostate cancer
Darren Poon • 18 May 2022
Abiraterone for the treatment of cN1 prostate cancer
1:17
Abiraterone for the treatment of cN1 prostate cancer
Darren Poon • 18 May 2022

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals